AI is transforming the software landscape, with many organizations integrating AI-driven workflows directly into their ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate as it looks to become an AI agent orchestration platform. UIPath's ...

UiPath Test Cloud recognized among top autonomous testing solutions with highest possible scores in vision, roadmap, and five other criteria UiPath (NYSE: PATH), a global leader in agentic automation, ...

UiPath (PATH) posted its first GAAP profit with $13M in operating income on $411M revenue. UiPath achieved an 83% gross margin. Palantir (PLTR) grew revenue 63% to $1.18B with U.S. commercial revenue ...

(RTTNews) - UiPath Inc. (PATH) surged 23.79%, climbing $3.54 to $18.40, after announcing its entry into the Veeva AI Partner Program, which will integrate UiPath's automation platform with Veeva's ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has joined the Veeva AI Partner Program. As part of the program, UiPath will help simplify and orchestrate the complex, ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...